Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Complementation Tests

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Complement System

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

Hospitals-II

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in hospitals have...

Hospitals-I

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency<sup>1</sup>.

Clinical and experimental immunology·2020

Same author

Thrombalexins: Cell-Localized Inhibition of Thrombin and Its Effects in a Model of High-Risk Renal Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Same author

Further studies of the down-regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotype.

Clinical and experimental immunology·2015

Same author

Studies with monoclonal antibodies to complement components.

Immunology today·2014

Same author

Complotype affects the extent of down-regulation by Factor I of the C3b feedback cycle in vitro.

Clinical and experimental immunology·2014

Same author

Tissue-and metal-specific effects of thiolacrylic acids in rats.

Biological trace element research·2013

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Taking complement to the clinic--has the time finally come?

P J Lachmann¹, R A G Smith

¹Department of Veterinary Medicine, University of Cambridge, Cambridge, UK. pjl1000@cam.ac.uk

Scandinavian Journal of Immunology

|May 15, 2009

Summary

The complement system, crucial for immunity, is now a promising therapeutic target for inflammatory diseases. New treatments are emerging to harness complement function for treating conditions like age-related macular degeneration.

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

Published on: January 20, 2019

Related Experiment Videos

Last Updated: Jun 23, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

Published on: January 20, 2019

Area of Science:

Immunology
Pharmacology
Genetics

Background:

The complement system's role in immunity and inflammation is well-established.
Translating complement knowledge into effective treatments for immunopathological diseases has been challenging.
Recent discoveries link complement system mutations to hyperinflammatory states in diseases like age-related macular degeneration.

Purpose of the Study:

To review the therapeutic potential of targeting the complement system.
To discuss emerging strategies for developing complement-based therapeutics.
To explore clinical applications and indications for complement-targeted therapies.

Main Methods:

Review of existing literature on complement system function.
Analysis of recent advancements in complement-targeting drug development.
Discussion of genetic links between complement dysregulation and disease.

Main Results:

New therapeutic agents designed to modulate complement activity are under development.
The complement system is increasingly recognized as a key factor in diseases previously considered untreatable.
Genetic mutations in the complement system can lead to hyperinflammatory conditions.

Conclusions:

The complement system presents a significant and revitalized therapeutic target.
Developing complement-based therapies holds promise for treating various inflammatory and immunopathological diseases.
Clinical translation of complement therapeutics is becoming increasingly feasible, with specific indications emerging.